Recruiting PHASE1 INTERVENTIONAL 1-arm
NCT07205289
Serum Collection Study for Assay Development
A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation
Sponsor: GPN Vaccines
Interventions
Gamma-PN
Updated 1 time since 2025 Last updated: Sep 25, 2025 Started: Oct 31, 2025 Primary completion: Jan 31, 2026 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1 trial investigates Pneumococcal Disease and Pneumococcal Disease, Invasive and is currently actively recruiting participants. GPN Vaccines leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- GPN Vaccines
Data source: GPN Vaccines
For direct contact, visit the study record on ClinicalTrials.gov .